Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12582599 | Methods for treatment of bladder cancer with gemcitabine | 🖼🧊📄§ | 2026-03-24 | 2042-07-07 | 0 | 31 |
| 12583925 | Bispecific antibodies targeting PD1 and VEGF | 🖼🧊📄§ | 2026-03-24 | 2044-09-26 | 0 | 31 |
| 12584138 | Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies | 🖼🧊📄§ | 2026-03-24 | 2041-08-26 | 0 | 31 |
| 12584120 | PCSK9 inhibitors and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2043-01-25 | 0 | 31 |
| 12582640 | Treatment of lower respiratory tract infection with tradipitant | 🖼🧊📄§ | 2026-03-24 | 2041-03-24 | 0 | 31 |
| 12582106 | IL-15 humanized mouse model and use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-12-24 | 0 | 31 |
| 12582693 | Glutathione trisulfide (GSSSG) in neuroprotection | 🖼🧊📄§ | 2026-03-24 | 2041-05-11 | 0 | 31 |
| 12582609 | Cancer vaccines | 🖼🧊📄§ | 2026-03-24 | 2036-10-21 | 0 | 31 |
| 12583934 | Anti-CD26 antibodies and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2042-09-16 | 0 | 31 |
| 12582653 | Method for treating idiopathic pulmonary fibrosis | 🖼🧊📄§ | 2026-03-24 | 2040-06-24 | 0 | 31 |
| 12582662 | Injectable pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent and a preservative | 🖼🧊📄§ | 2026-03-24 | 2043-05-26 | 0 | 31 |
| 12582613 | Biomimetic, reactive oxygen species-detonable nanoclusters for antirestenotic therapy | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12582672 | Vanadium compositions and methods for treatment of cancer | 🖼🧊📄§ | 2026-03-24 | 2039-11-13 | 0 | 31 |
| 12582719 | Chimeric compounds and methods of managing neurological disorders or conditions | 🖼🧊📄§ | 2026-03-24 | 2040-02-25 | 0 | 31 |
| 12582704 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | 🖼🧊📄§ | 2026-03-24 | 2044-08-09 | 0 | 31 |
| 12582708 | Recombinant influenza viruses comprising truncated NS1 fusion proteins | 🖼🧊📄§ | 2026-03-24 | 2040-02-10 | 0 | 31 |
| 12582689 | Use of terpenoids in the treatment or prevention of fibrotic diseases | 🖼🧊📄§ | 2026-03-24 | 2041-05-19 | 0 | 31 |
| 12582679 | Compositions and methods for the treatment of allergy | 🖼🧊📄§ | 2026-03-24 | 2041-04-19 | 0 | 31 |
| 12582638 | Pharmaceutical composition for treating cancer, containing mTOR-signaling inhibitor as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2041-02-19 | 0 | 31 |
| 12582649 | Compositions and methods for hair follicle regeneration | 🖼🧊📄§ | 2026-03-24 | 2041-06-03 | 0 | 31 |
| 12582709 | Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways | 🖼🧊📄§ | 2026-03-24 | 2041-07-01 | 0 | 31 |
| 12582632 | Inhibition of neurological injuries due to infections via administration of Butanetap and analogs thereof | 🖼🧊📄§ | 2026-03-24 | 2042-05-17 | 0 | 31 |
| 12582617 | Methods for treating cancer | 🖼🧊📄§ | 2026-03-24 | 2042-06-29 | 0 | 31 |
| 12583822 | Benzylamine derivative, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-07-28 | 0 | 31 |
| 12583914 | Methods of treating allergy using anti-bet v 1 antibodies | 🖼🧊📄§ | 2026-03-24 | 2043-12-19 | 0 | 31 |
| 12583895 | Polypeptides for restoring endothelial function and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12583848 | Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |
| 12582648 | Method for treating central nervous system disorders using dopamine D3 partial agonists | 🖼🧊📄§ | 2026-03-24 | 2041-05-04 | 0 | 31 |
| 12583892 | Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors | 🖼🧊📄§ | 2026-03-24 | 2042-06-28 | 0 | 31 |
| 12583891 | Peptides and methods for the treatment of diabetes | 🖼🧊📄§ | 2026-03-24 | 2043-08-08 | 0 | 31 |
| 12582696 | Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease | 🖼🧊📄§ | 2026-03-24 | 2040-12-10 | 0 | 31 |
| 12582706 | Tolerogenic antigen presenting cells | 🖼🧊📄§ | 2026-03-24 | 2040-12-11 | 0 | 31 |
| 12584136 | Aptamers for personal health care applications | 🖼🧊📄§ | 2026-03-24 | 2042-12-14 | 0 | 31 |
| 12583903 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | 🖼🧊📄§ | 2026-03-24 | 2042-06-03 | 0 | 31 |
| 12584149 | Nuclease-mediated genome editing of primary cells and related kits | 🖼🧊📄§ | 2026-03-24 | 2042-12-05 | 0 | 31 |
| 12582651 | Pharmaceutical composition comprising tadalafil or pharmaceutically acceptable salt thereof and dutasteride or pharmaceutically acceptable salt thereof exhibiting novel dissolution rate | 🖼🧊📄§ | 2026-03-24 | 2041-12-30 | 0 | 31 |
| 12582697 | Antisecretory factor for use in treatment and/or prevention of acute respiratory failure | 🖼🧊📄§ | 2026-03-24 | 2039-06-26 | 0 | 31 |
| 12584147 | Rational polyploid adeno-associated virus vectors for the treatment of disease | 🖼🧊📄§ | 2026-03-24 | 2043-05-19 | 0 | 31 |
| 12582676 | Hydrogel particle encapsulated viable cells for in vivo regenerative treatment | 🖼🧊📄§ | 2026-03-24 | 2043-07-18 | 0 | 31 |
| 12584137 | Aptamers for personal health care applications | 🖼🧊📄§ | 2026-03-24 | 2042-12-14 | 0 | 31 |
| 12582614 | Composition for preventing, alleviating or treating sarcopenia, containing D-ribo-2-hexulose as active ingredient | 🖼🧊📄§ | 2026-03-24 | 2042-03-04 | 0 | 31 |
| 12582631 | Methods of improving renal function | 🖼🧊📄§ | 2026-03-24 | 2042-08-16 | 0 | 31 |
| 12582635 | Compositions and methods for treating cancer with atypical BRAF mutations | 🖼🧊📄§ | 2026-03-24 | 2038-05-15 | 0 | 31 |
| 12582670 | Lignin solvation using aqueous biologically compatible buffers | 🖼🧊📄§ | 2026-03-24 | 2040-01-10 | 0 | 31 |
| 12582695 | Compositions and methods for treating glioma | 🖼🧊📄§ | 2026-03-24 | 2039-11-27 | 0 | 31 |
| 12583911 | Human immunodeficiency virus GP120 binding proteins | 🖼🧊📄§ | 2026-03-24 | 2043-10-31 | 0 | 31 |
| 12582627 | MCT formulations for improving cognitive functions | 🖼🧊📄§ | 2026-03-24 | 2041-05-17 | 0 | 31 |
| 12583912 | Flavivirus cross neutralizing antibody and pharmaceutical composition | 🖼🧊📄§ | 2026-03-24 | 2041-02-04 | 0 | 31 |
| 12583900 | Peptide conjugates and methods of use | 🖼🧊📄§ | 2026-03-24 | 2040-12-03 | 0 | 31 |
| 12583888 | Bi-specific extracellular matrix binding peptides and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |